This program has concluded

Return to Classroom
Loading the player...


The 5 Toughest Issues in Cannabis M&A

In any industry, M&A is challenging. In cannabis, the issues can be even more complex. This deeper dive panel will focus on five of the most difficult legal issues to manage in these transactions. They include: non-competes/non-solicitations, earn-out provisions, implications of cash vs. stock components in consideration, consideration dependent on future legalization efforts, and clarifying state approval processes for transactions. Join this panel to hear more about these challenging issues and the best strategies for addressing them in individual transactions.

David Feldman, Managing Partner, Feldman Legal Advisors PLLC
Catia Kossovsky, Esq., Managing Member, Smart Counsel
Samantha Gleit, Partner, Feuerstein Kulick LLP

Samantha Gleit is a partner at Feuerstein Kulick, focusing on debt and equity financing, corporate restructuring, alternative capital sources, acquisition financing, senior and mezzanine investments, and related commercial transactions.  In 2021, Samantha was  selected by Law360 as a “Rising Star” in the cannabis industry for top attorneys under 40 whose legal accomplishments transcend their age.

 Throughout her career, Samantha has advised institutional and alternative investors on distressed debt and high risk lending.  She is known for implementing tailored, regulatory-compliant, loan and workout structures designed to maximize protection in the evolving  cannabis legal landscape. Samantha also has extensive experience advising companies (ranging from startups to large public companies) on debt structure, risk management, workouts, acquisition financing, capitalization and compliance. Beyond traditional legal  advice, Samantha also assists startups and growing companies identify liquidity sources, develop growth strategies and negotiate efficient financing solutions. 

 Recent representations include GlassHouse; Jushi; Holistic; Loudpack; lenders to Curaleaf, Terrascend, and Cresco; cannabis-focused REITs, a private lender in a $250 million senior secured credit facility with the factoring arm of a wholesale B2B marketplace;  Navy Capital in leading in a private placement of convertible debt with 4Front; and FocusGrowth Capital Partners on debt and equity financings with various multi-state and single state operators. 

 Samantha is regularly interviewed and published in leading debt media outlets. In addition to being selected as a top cannabis lawyer under 40 in 2021 by Law360, Samantha was selected as a Rising Star in the 2015 – 2021 editions of New York Metro Super Lawyers®  and featured in The New York Times Magazine Super Lawyers® Top Women Attorneys in the New York Metro Area. Samantha is regularly interviewed by legal publications on debt and equity financing in the cannabis industry. She has also co-authored an article featured  on the cover of the ABI Journal discussing suggested reforms to the federal bankruptcy process.  In 2013, Samantha was awarded the International Bar Association’s Insolvency Scholarship for her award winning article on distressed law firms. Prior to joining  Feuerstein Kulick, Samantha worked at King & Spalding LLP in New York, in the corporate finance and investments group.

Neil Kaufman, Kaufman McGowan PLLC

One of the leading corporate cannabis lawyers in the USA, having participated in over $2 Billion of cannabis industry financing, M&A and other transactions.

Daniel Haymann, MBA, Senior Associate, MLL Meyerlustenberger Lachenal Froriep Ltd

Daniel Haymann’s practice focuses on international and domestic commercial litigation and arbitration as well as corporate and commercial law.

He established the first dedicated cannabis desk at a large law firm in Switzerland and advises investors, start-ups and vertically integrated companies in the cannabis industry along the value chain, including, among others, on regulatory matters (advice includes all regulatory aspects relating to THC, CBD and other cannabinoids; cultivation and distribution, including GMP and GDP standards, as well as retail; EU Novel Food; cosmetics law; medicinal cannabis products under the supervisory authority Swissmedic (as well as Herbal Medicines)).

He gained extensive experience as a commodity trader and in managerial positions in the coal, petroleum coke and fertiliser industries for the two leading international commodity trading firms in their respective fields. He was based in Zurich, Baar, Singapore and Hong Kong. He then joined an International Finance and Business Development Boutique as partner and held management positions in corporate business development.


Download Google Crome Browser Download Firefox Browser
Restart the Seminar
Restart Section